IONS Ionis Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 29, 2026
$43,54
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$43,0152-Wochen-Tief
$86,7452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$7.21B
P/E (TTM)
-12.6
EPS (TTM)
$-3.46
Umsatz (TTM)
$874M
Ihre Abzeichen
52W-Spanne
$43–$87
Analystenbewertung
BUY
Kursziel
$84
P/E
-12.6
ROE
-105.5%
Nettogewinnmarge
-64.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
IONS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$43.54
Marktkapitalisierung (MRQ)
$7.21B
P/E (TTM)
-12.6
EPS (TTM)
$-3.46
Umsatz (TTM)
$874M
ROE (TTM)
-105.5%
Verschuldungsgrad
3.6
52W-Spanne
$43–$87
IONS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2016-12-31 → 2017-12-31
EPS$-2.382016-12-31 → 2025-12-31
Freier Cashflow$-320M2016-12-31 → 2025-12-31
Nettogewinnmarge-64.7%2016-12-31 → 2017-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | IONS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -12.65-Jahres-Durchschnitt ≈-47.3 | ≈-47.3 | · | · | |
| P/S (TTM) | 8.35-Jahres-Durchschnitt ≈9.0 | ≈9.0 | 150.3 | Unterbewertet | |
| K/B (MRQ) | 16.45-Jahres-Durchschnitt ≈13.9 | ≈13.9 | 10.8 | Überbewertet | |
| EV / EBITDA | -16.25-Jahres-Durchschnitt ≈-17.4 | ≈-17.4 | · | · | |
| Kurs / FCF (TTM) | -12.95-Jahres-Durchschnitt ≈27.4 | ≈27.4 | · | · | |
| Kurs / Cashflow (TTM) | -14.55-Jahres-Durchschnitt ≈7.4 | ≈7.4 | · | · | |
| EV / Revenue (EV / Umsatz) | 6.65-Jahres-Durchschnitt ≈8.7 | ≈8.7 | · | · | |
| EV / FCF | -19.45-Jahres-Durchschnitt ≈-20.0 | ≈-20.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 14.55-Jahres-Durchschnitt ≈14.0 | ≈14.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | IONS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -68.0% | · | -2340.3% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -64.3% | · | -552.9% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -64.7% | · | -1588.5% | Spitzenklasse | |
| ROA (TTM) | -18.9%5-Jahres-Durchschnitt ≈-10.3% | ≈-10.3% | -42.7% | Spitzenklasse | |
| ROE (TTM) | -105.5%5-Jahres-Durchschnitt ≈-57.6% | ≈-57.6% | -68.1% | Im Einklang | |
| ROIC | -17.1%5-Jahres-Durchschnitt ≈-19.0% | ≈-19.0% | -33.2% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | IONS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Debt / Equity (Fremdkapital / Eigenkapital) | 3.65-Jahres-Durchschnitt ≈2.7 | ≈2.7 | 0.9 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 7.95-Jahres-Durchschnitt ≈7.0 | ≈7.0 | 7.9 | Im Einklang | |
| Quick Ratio | 3.45-Jahres-Durchschnitt ≈5.2 | ≈5.2 | 6.8 | Geringe Liquidität | |
| Long-Term Debt / Equity (Langfristige Schulden / Eigenkapital) | 2.75-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 0.8 | Hohe Verschuldung | |
| Interest Coverage (Zinsdeckungsgrad) | -22.15-Jahres-Durchschnitt ≈-26.3 | ≈-26.3 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | IONS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Inventory Turnover (Lagerumschlag) | 1.45-Jahres-Durchschnitt ≈0.8 | ≈0.8 | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
64.3%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 28, 2026 | $-0.69 | $-1.09 | 36.7% |
| 31. März 2026 | $-0.56 | $-0.93 | 39.7% | |
| 31. Dezember 2025 | $-1.41 | $-1.35 | -4.6% | |
| 30. September 2025 | $-0.80 | $-1.26 | 36.4% | |
| 30. Juni 2025 | $0.70 | $-0.44 | 259.6% | |
| 31. März 2025 | $-0.93 | $-1.14 | 18.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | $508M | $347M | $284M | $214M | |
| Cost of Revenue | $16M | $11M | $9M | $14M | $11M | $12M | $4M | $2M | $0 | $0 | · | · | |
| R&D Expense | $916M | $902M | $900M | · | $638M | $531M | $462M | $412M | $372M | $340M | $320M | $239M | |
| SG&A Expense | $394M | $267M | $233M | $150M | $186M | $354M | $287M | $245M | $108M | $49M | $37M | $20M | |
| Operating Expenses | $1.33B | $1.18B | $1.14B | $998M | $841M | $901M | $757M | $661M | $483M | $393M | $359M | $262M | |
| Operating Income | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $31M | $-20M | $-76M | $-48M | |
| Interest Expense | $17M | $17M | $13M | $8M | $9M | $10M | $12M | $45M | $45M | $39M | $37M | $22M | |
| Other Non-op | $-15M | $1M | $14M | $-7M | $-10M | $-62.0K | $-686.0K | $-182.0K | $-4M | $0 | · | · | |
| Pretax Income | $-380M | $-460M | $-334M | $-258M | $-29M | $-135M | $339M | $-76M | $-17M | $-57M | $-88M | $-54M | |
| Income Tax | $2M | $-6M | $32M | $12M | $-551.0K | $345M | $52M | $-291M | $-6M | $3M | $372.0K | $-15M | |
| Net Income | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| EPS (Basic) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $2.00 | $2.09 | $0.15 | $-0.50 | $-0.74 | · | |
| EPS (Diluted) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $1.90 | $2.07 | $0.15 | $-0.50 | $-0.74 | · | |
| Shares (Basic) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 139,998,000 | 132,320,000 | 124,016,000 | 120,933,000 | 119,719,000 | · | |
| Shares (Diluted) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 153,164,000 | 134,056,000 | 126,098,000 | 120,933,000 | 119,719,000 | · | |
| EBITDA | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $25M | $-46M | $-76M | $-48M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $372M | $242M | $399M | $276M | $869M | $398M | $683M | $279M | $130M | $85M | $129M | $143M | |
| Short-term Investments | $2.31B | $2.06B | $1.93B | $1.71B | $1.25B | · | · | · | · | · | · | · | |
| Inventory | $10M | $13M | $7M | $22M | $25M | $22M | $18M | $9M | $10M | · | · | · | |
| Other Current Assets | $237M | $218M | $205M | $168M | $143M | $140M | $140M | $102M | $73M | $17M | $15M | $16M | |
| Current Assets | $2.99B | $2.62B | $2.64B | $2.20B | $2.35B | $2.13B | $2.72B | $2.21B | $1.17B | $798M | $837M | $837M | |
| PP&E (Net) | $123M | $94M | $71M | $74M | $178M | $181M | $154M | $132M | $122M | $93M | $90M | $89M | |
| Accum. Depreciation | $109M | $106M | $97M | $88M | $103M | $87M | $74M | $61M | $88M | $80M | $73M | $66M | |
| Intangibles | · | · | · | · | $29M | $28M | $26M | $24M | $22M | $20M | · | · | |
| Other Non-current Assets | $172M | $127M | $105M | $75M | $71M | $50M | $28M | $13M | $10M | $1M | · | · | |
| Total Assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Accounts Payable | $28M | $43M | $26M | $18M | $12M | $17M | $16M | $29M | $25M | $21M | $28M | $18M | |
| Accrued Liabilities | $106M | $108M | $148M | $140M | $89M | $90M | $67M | $48M | $67M | $36M | $28M | $30M | |
| Current Liabilities | $782M | $309M | $448M | $312M | $241M | $599M | $273M | $280M | $244M | $134M | $149M | $115M | |
| Capital Leases | $262M | $162M | $171M | $179M | $19M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $28M | $52M | $42M | $16M | $7M | · | · | · | · | · | · | · | |
| Total Liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B | $1.65B | $1.55B | $1.48B | $957M | $813M | $747M | $698M | |
| Long-term Debt | $1.81B | $1.25B | $1.31B | $1.19B | · | · | · | · | · | · | · | · | |
| Total Debt | $1.76B | $1.20B | $1.24B | $1.18B | · | · | · | · | · | · | · | · | |
| Common Stock | $163.0K | $158.0K | $144.0K | $142.0K | $141.0K | $140.0K | $140.0K | $138.0K | $125.0K | $122.0K | $120.0K | $118.0K | |
| Retained Earnings | $-2.63B | $-2.25B | $-1.80B | $-1.43B | $-1.16B | $-1.13B | $-708M | $-967M | $-1.24B | $-1.18B | $-1.09B | $-1.01B | |
| AOCI | $-25M | $-31M | $-33M | $-57M | $-33M | $-21M | $-25M | $-32M | $-32M | $-30M | $-14M | $40M | |
| Stockholders' Equity | $489M | $588M | $387M | $573M | $772M | $743M | $1.47B | $1.05B | $281M | $100M | $201M | $258M | |
| Liabilities + Equity | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Shares Outstanding | 163,304,875 | 157,908,815 | 144,340,526 | 142,057,736 | 141,210,015 | 140,365,594 | 140,339,615 | 137,928,828 | 124,976,373 | 121,636,273 | 120,351,480 | 118,442,726 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $134M | $130M | $106M | $100M | $121M | $230M | $147M | $131M | $86M | $72M | $59M | $31M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $342M | $904.0K | $-291M | $0 | $0 | $0 | $-11M | |
| Amort. of Intangibles | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Operating Cash Flow | $-269M | $-501M | $-308M | $-274M | $31M | $36M | $346M | $603M | $174M | $-112M | $21M | $6M | |
| CapEx | $51M | $45M | $24M | $16M | $12M | $35M | $31M | $14M | $35M | $7M | $8M | $8M | |
| Investing Cash Flow | $-278M | $-134M | $-214M | $-263M | $195M | $274M | $-41M | $-930M | $-358M | $57M | $-60M | · | |
| Stock Issued | $0 | $489M | $0 | $0 | · | $0 | $0 | $448M | $72M | $0 | $0 | $0 | |
| Stock Repurchased | · | · | · | $0 | $0 | $91M | $34M | $0 | $0 | · | · | · | |
| Net Stock Activity | $0 | $489M | · | $0 | $0 | $-91M | $-34M | · | $72M | · | $0 | $0 | |
| Financing Cash Flow | $676M | $478M | $644M | $-55M | $246M | $-597M | $100M | $476M | $229M | $11M | $25M | · | |
| Net Change in Cash | $130M | $-157M | $123M | $-593M | $472M | $-286M | $404M | $149M | $45M | $-44M | $-14M | · | |
| Taxes Paid | $-639.0K | $-6M | $48M | $5M | · | $26M | $9M | $0 | $0 | · | · | · | |
| Free Cash Flow | $-320M | $-546M | $-331M | $-290M | $19M | $772.0K | $315M | $589M | $139M | $-119M | $13M | $-1M | |
| Levered FCF | $-337M | $-563M | $-345M | $-299M | $10M | $-128M | $272M | $716M | $106M | $-159M | $-23M | $-17M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -1.2% | -25.0% | -31.1% | -18.2% | |
| Pretax Margin | · | · | · | · | · | · | · | · | -4.6% | -24.1% | -31.0% | -25.4% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| ROA | -11.7% | -15.2% | -13.3% | -10.5% | -1.1% | -16.1% | 10.0% | 13.7% | -0.53% | -9.3% | -9.2% | -4.3% | |
| ROE | -68.1% | -71.9% | -104.3% | -40.1% | -3.8% | -39.0% | 23.4% | 41.2% | -2.8% | -57.6% | -38.5% | -12.3% | |
| ROIC | -17.1% | -26.0% | -23.8% | -24.5% | -3.8% | -58.4% | 21.8% | 16.5% | 5.5% | -48.1% | -37.9% | -13.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 | 3.7 | 10.0 | 7.9 | 5.2 | 6.0 | 5.6 | 7.3 | |
| Quick Ratio | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 | 0.7 | 2.5 | 1.0 | 0.6 | 0.6 | 0.9 | 1.2 | |
| Debt / Equity | 3.6 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 2.7 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | -22.1 | -28.0 | -27.9 | -50.5 | -3.2 | -3.8 | 7.5 | -1.4 | 0.5 | -1.2 | -2.1 | -2.1 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.5 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.4 | 1.1 | 0.4 | 0.6 | 0.5 | 0.6 | 0.3 | 0.2 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.99 | $3.80 | $2.68 | $4.03 | $5.47 | $6.01 | $10.48 | $7.60 | $2.65 | $0.82 | $1.67 | $2.18 | |
| Revenue / Share | · | · | · | · | · | · | · | · | $4.03 | · | · | · | |
| Cash Flow / Share | $-1.68 | $-3.35 | $-2.15 | $-1.93 | $0.22 | $0.26 | $2.42 | $4.50 | $1.38 | · | · | · | |
| Cash / Share | $2.28 | $1.53 | $2.77 | $1.95 | $6.16 | $2.83 | $4.87 | $2.02 | $1.04 | $0.70 | $1.07 | $1.21 | |
| EPS (TTM) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $1.90 | $2.07 | $0.15 | $-0.50 | $-0.74 | $-0.35 |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $944M | $705M | $788M | $587M | $810M | $729M | $1.12B | $600M | $508M | $347M | $284M | $214M | |
| Net Income TTM | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| Market Cap | $12.92B | $5.52B | $7.30B | $5.37B | $4.30B | $7.94B | $8.48B | $7.46B | $6.29B | $5.82B | $7.45B | $7.31B | |
| Enterprise Value | $12.00B | $4.43B | $6.21B | $4.55B | · | · | · | · | · | · | · | · | |
| P/E | -33.2 | -11.5 | -19.8 | -19.9 | -152.2 | -17.8 | 31.8 | 26.1 | 335.3 | -95.7 | -83.7 | -176.4 | |
| P/S | 13.7 | 7.8 | 9.3 | 9.1 | 5.3 | 10.9 | 7.6 | 12.4 | 12.4 | 16.8 | 26.3 | 34.1 | |
| P/B | 26.4 | 9.2 | 18.9 | 9.4 | 5.6 | 9.4 | 5.8 | 7.1 | 19.0 | 58.4 | 37.1 | 28.4 | |
| P / Tangible Book | 26.4 | 9.4 | 18.9 | 9.4 | 5.8 | 11.1 | · | · | · | · | · | · | |
| P / Cash Flow | -48.1 | -11.0 | -23.7 | -19.6 | 139.5 | 221.1 | 24.5 | 12.4 | 36.1 | -51.9 | 352.8 | 1163.5 | |
| P / FCF | -40.4 | -10.1 | -22.0 | -18.5 | 228.0 | 10280.1 | 26.9 | 12.7 | 45.1 | -48.8 | 554.9 | -5930.8 | |
| EV / EBITDA | -31.4 | -9.3 | -17.6 | -11.1 | · | · | · | · | · | · | · | · | |
| EV / FCF | -37.5 | -8.1 | -18.7 | -15.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 12.7 | 6.3 | 7.9 | 7.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -3.0% | -8.7% | -5.1% | -5.0% | -0.66% | -5.6% | 3.1% | 3.8% | 0.30% | -1.1% | -1.2% | -0.57% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $246M | $203M | $157M | $452M | $132M | $227M | $134M | $225M | $119M | $325M | $144M | $188M | $131M | $152M | $160M | |
| Cost of Revenue | $3M | $3M | $8M | $2M | $4M | $1M | $4M | $1M | $4M | $2M | $3M | $2M | $3M | $1M | $4M | $2M | |
| SG&A Expense | $150M | $150M | $130M | $97M | $91M | $76M | $88M | $62M | $65M | $53M | $71M | $70M | $46M | $46M | $48M | $34M | |
| Operating Expenses | $370M | $364M | $418M | $317M | $312M | $278M | $337M | $282M | $291M | $269M | $331M | $287M | $279M | $245M | $360M | $219M | |
| Operating Income | $-102M | $-117M | $-214M | $-160M | $140M | $-147M | $-111M | $-149M | $-66M | $-150M | $-6M | $-143M | $-90M | $-114M | $-208M | $-59M | |
| Interest Expense | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $2M | $2M | $2M | $2M | |
| Other Non-op | $987.0K | $-456.0K | $-16M | $363.0K | $102.0K | $465.0K | $302.0K | $142.0K | $610.0K | $277.0K | $235.0K | $2M | $11M | $230.0K | $123.0K | $5M | |
| Pretax Income | $-113M | $-92M | $-228M | $-128M | $124M | $-147M | $-107M | $-144M | $-66M | $-143M | $-3M | $-141M | $-77M | $-113M | $-44M | $-47M | |
| Income Tax | $1M | $218.0K | $1M | $213.0K | $-20.0K | $116.0K | $-3M | $-4M | $64.0K | $75.0K | $6M | $7M | $8M | $11M | $8M | $283.0K | |
| Net Income | $-115M | $-93M | $-229M | $-129M | $124M | $-147M | $-104M | $-140M | $-66M | $-143M | $-9M | $-147M | $-85M | $-124M | $-52M | $-47M | |
| EPS (Basic) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.78 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| EPS (Diluted) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.70 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| Shares (Basic) | 165,419,000 | 164,874,000 | · | 159,765,000 | 159,137,000 | 158,735,000 | · | 148,593,000 | 145,958,000 | 145,538,000 | · | 143,317,000 | 143,098,000 | 142,735,000 | · | 141,950,000 | |
| Shares (Diluted) | 165,419,000 | 164,874,000 | · | 159,765,000 | 182,331,000 | 158,735,000 | · | 148,593,000 | 145,958,000 | 145,538,000 | · | 143,317,000 | 143,098,000 | 142,735,000 | · | 141,950,000 | |
| EBITDA | $-102M | $-117M | · | $-160M | $140M | $-147M | · | $-149M | $-66M | $-150M | · | $-143M | $-90M | $-114M | · | $-59M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $350M | $173M | $372M | $338M | $297M | $264M | $242M | $335M | $294M | $349M | · | $352M | $425M | $309M | · | $315M | |
| Short-term Investments | $1.70B | $1.75B | $2.31B | $1.90B | $1.99B | $1.88B | $2.06B | $2.15B | $1.78B | $1.86B | · | $1.88B | $1.96B | $2.04B | · | $1.67B | |
| Inventory | $51M | $6M | $10M | $10M | $8M | $12M | $13M | $28M | $29M | $30M | · | $26M | $26M | $22M | · | $21M | |
| Other Current Assets | $327M | $306M | $237M | $244M | $226M | $223M | $218M | $184M | $195M | $174M | · | $181M | $178M | $160M | · | $143M | |
| Current Assets | $2.49B | $2.94B | $2.99B | $2.52B | $2.58B | $2.42B | $2.62B | $2.71B | $2.33B | $2.42B | · | $2.58B | $2.62B | $2.54B | · | $2.15B | |
| PP&E (Net) | $155M | $142M | $123M | $106M | $112M | $103M | $94M | $83M | $76M | $73M | · | $71M | $92M | $85M | · | $181M | |
| Accum. Depreciation | · | · | $109M | · | · | · | $106M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $117M | $136M | $172M | $166M | $132M | $132M | $127M | $120M | $119M | $106M | · | $104M | $86M | $78M | · | $59M | |
| Total Assets | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Accounts Payable | $48M | $26M | $28M | $14M | $23M | $17M | $43M | $9M | $9M | $13M | · | $6M | $24M | $10M | · | $21M | |
| Accrued Liabilities | $116M | $127M | $106M | $99M | $99M | $103M | $108M | $124M | $114M | $106M | · | $119M | $105M | $113M | · | $128M | |
| Current Liabilities | $316M | $717M | $782M | $903M | $897M | $250M | $309M | $305M | $306M | $328M | · | $404M | $288M | $259M | · | $283M | |
| Capital Leases | $262M | $259M | $262M | $263M | $164M | $159M | $162M | $168M | $166M | $169M | · | $173M | $175M | $177M | · | · | |
| Other Non-current Liabilities | $28M | $28M | · | $29M | $59M | $56M | · | $42M | $42M | $42M | · | $49M | $16M | $7M | · | · | |
| Total Liabilities | $2.55B | $2.96B | $3.03B | $2.42B | $2.35B | $2.34B | $2.42B | $2.42B | $2.43B | $2.47B | · | $2.62B | $2.54B | $2.40B | · | $1.83B | |
| Long-term Debt | · | · | $1.81B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $166.0K | $166.0K | $163.0K | $161.0K | $159.0K | $159.0K | $158.0K | $158.0K | $146.0K | $146.0K | · | $143.0K | $143.0K | $143.0K | · | $142.0K | |
| Retained Earnings | $-2.84B | $-2.72B | $-2.63B | $-2.40B | $-2.27B | $-2.40B | $-2.25B | $-2.15B | $-2.00B | $-1.94B | · | $-1.79B | $-1.64B | $-1.55B | · | $-1.38B | |
| AOCI | $-34M | $-31M | $-25M | $-26M | $-28M | $-29M | $-31M | $-24M | $-35M | $-35M | · | $-46M | $-51M | $-49M | · | $-63M | |
| Stockholders' Equity | $440M | $491M | $489M | $618M | $632M | $476M | $588M | $662M | $264M | $297M | $387M | $315M | $428M | $487M | $573M | $594M | |
| Liabilities + Equity | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Shares Outstanding | 165,636,792 | 165,902,064 | 163,304,875 | 161,137,930 | 159,196,782 | 159,041,259 | 157,908,815 | 157,813,136 | 146,025,246 | 145,844,719 | · | 143,393,493 | 143,167,414 | 143,022,539 | · | 142,017,411 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $46M | $43M | $43M | $31M | $30M | $30M | $36M | $32M | $31M | $31M | $26M | $26M | $27M | $27M | $26M | $24M | |
| Amort. of Intangibles | $700.0K | $661.0K | $638.0K | $621.0K | $598.0K | $582.0K | $459.0K | $617.0K | $621.0K | $639.0K | $655.0K | $660.0K | $637.0K | $607.0K | $610.0K | $608.0K | |
| Operating Cash Flow | $566M | $-793M | $-138M | $-131M | $151M | $-151M | $-116M | $-115M | $-120M | $-150M | $33M | $-109M | $-97M | $-134M | $-200M | $-24M | |
| CapEx | $16M | $22M | $21M | $5M | $12M | $13M | $25M | $9M | $6M | $4M | $-819.0K | $2M | $12M | $10M | $4M | $6M | |
| Investing Cash Flow | $23M | $537M | $-420M | $91M | $-120M | $170M | $68M | $-341M | $62M | $76M | $-27M | $69M | $70M | $-326M | $212M | $-184M | |
| Stock Issued | · | · | $0 | · | · | · | $27.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $-412M | $57M | $591M | $81M | $1M | $2M | $-44M | $496M | $3M | $24M | $41M | $-32M | $144M | $492M | $-51M | $2M | |
| Net Change in Cash | $177M | $-199M | $34M | $41M | $33M | $22M | $-93M | $41M | $-55M | $-50M | $47M | $-73M | $116M | $33M | $-39M | $-207M | |
| Taxes Paid | $1M | $-8.0K | $22.0K | $-278.0K | $17.0K | $-400.0K | $-8M | $80.0K | $2M | $13.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | $-815M | · | · | · | $-163M | · | · | · | $-154M | · | · | · | $-144M | · | · | |
| Levered FCF | · | $-820M | · | · | · | $-167M | · | · | · | $-159M | · | · | · | $-146M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| Net Margin | -42.8% | -37.6% | · | -82.1% | 27.3% | -111.6% | · | -105.0% | -29.4% | -119.5% | · | -102.2% | -45.3% | -95.2% | · | -29.4% | |
| Pretax Margin | -42.3% | -37.5% | · | -81.9% | 27.3% | -111.6% | · | -107.7% | -29.4% | -119.4% | · | -97.6% | -41.1% | -86.5% | · | -29.2% | |
| EBITDA Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| ROA | -3.8% | -2.9% | · | -4.2% | 4.3% | -5.3% | · | -4.7% | -2.3% | -5.1% | · | -5.5% | -3.1% | -4.6% | · | -1.9% | |
| ROE | -21.4% | -19.1% | · | -20.1% | 27.6% | -38.0% | · | -28.7% | -19.1% | -36.5% | · | -32.4% | -16.2% | -20.8% | · | -8.3% | |
| ROIC | -23.5% | -23.9% | · | -26.0% | 22.1% | -30.9% | · | -21.9% | -25.1% | -50.4% | · | -47.5% | -23.2% | -25.8% | · | -10.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 4.1 | · | 2.8 | 2.9 | 9.7 | · | 8.9 | 7.6 | 7.4 | · | 6.4 | 9.1 | 9.8 | · | 7.6 | |
| Quick Ratio | 6.5 | 2.7 | · | 2.5 | 2.6 | 8.6 | · | 8.2 | 6.8 | 6.7 | · | 5.5 | 8.3 | 9.1 | · | 7.0 | |
| Interest Coverage | -22.2 | -22.8 | · | -38.0 | 34.0 | -35.7 | · | -35.7 | -14.7 | -36.0 | · | -34.1 | -39.4 | -71.0 | · | -27.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.3 | · | 0.1 | 0.2 | 0.1 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.65 | $2.96 | · | $3.83 | $3.97 | $2.99 | · | $4.20 | $1.81 | $2.03 | · | $2.20 | $2.99 | $3.40 | · | $4.19 | |
| Revenue / Share | $1.62 | $1.49 | · | $0.98 | $2.48 | $0.83 | · | $0.90 | $1.54 | $0.82 | · | $1.01 | $1.32 | $0.91 | · | $1.13 | |
| Cash Flow / Share | · | $-4.81 | · | · | · | $-0.95 | · | · | · | $-1.03 | · | · | · | $-0.94 | · | · | |
| Cash / Share | $2.11 | $1.05 | · | $2.10 | $1.87 | $1.66 | · | $2.12 | $2.01 | $2.39 | · | $2.46 | $2.97 | $2.16 | · | $2.22 | |
| EPS (TTM) | $-3.46 | $-2.07 | · | $-1.69 | $-1.84 | $-2.99 | · | $-2.44 | $-2.52 | $-2.67 | · | $-2.87 | $-2.17 | $-2.31 | · | $0.06 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $874M | $1.06B | · | $967M | $944M | $717M | · | $803M | $813M | $777M | · | $615M | $631M | $576M | · | $875M | |
| Net Income TTM | $-565M | $-327M | · | $-256M | $-268M | $-458M | · | $-359M | $-366M | $-385M | · | $-409M | $-309M | $-329M | · | $7M | |
| Market Cap | $13.13B | $12.46B | · | $10.54B | $6.29B | $4.80B | · | $6.32B | $6.96B | $6.32B | · | $6.50B | $5.87B | $5.11B | · | $6.28B | |
| P/E | -22.9 | -36.3 | · | -38.7 | -21.5 | -10.1 | · | -16.4 | -18.9 | -16.2 | · | -15.8 | -18.9 | -15.5 | · | 737.2 | |
| P/S | 15.0 | 11.8 | · | 10.9 | 6.7 | 6.7 | · | 7.9 | 8.6 | 8.1 | · | 10.6 | 9.3 | 8.9 | · | 7.2 | |
| P/B | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 10.6 | |
| P / Tangible Book | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 11.1 | |
| P / Cash Flow | · | -15.7 | · | · | · | -31.8 | · | · | · | -42.2 | · | · | · | -38.1 | · | · | |
| Earnings Yield | -4.4% | -2.8% | · | -2.6% | -4.7% | -9.9% | · | -6.1% | -5.3% | -6.2% | · | -6.3% | -5.3% | -6.5% | · | 0.14% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-381M | $-454M | $-366M | $-270M | $-29M |
| Verwässerte EPS | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 3.6 | 2.0 | 3.2 | 2.1 | · |
| Liquiditätsgrad | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 |
| Quick Ratio | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-320M | $-546M | $-331M | $-290M | $19M |
Institutionelle Eigentümer (13F) 571 Einreicher · $15.7B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
571
Gehaltener Wert
$15.7B
Neue Positionen
73
Geschlossene Positionen
41
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 73 (-19 vs. Vorquartal) | 41 (-24 vs. Vorquartal) | 213 (+26 vs. Vorquartal) | 159 (+3 vs. Vorquartal) | +10.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $1.953.067.764 | 24.631.956 | 12,47% | Aktien |
| Capital World Investors | $1.718.152.930 | 21.669.226 | 10,97% | Aktien |
| VANGUARD GROUP INC | $1.300.604.712 | 16.440.459 | 8,31% | Aktien |
| BlackRock, Inc. | $848.772.532 | 10.704.660 | 5,42% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $623.182.054 | 7.859.529 | 3,98% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $606.680.694 | 7.651.415 | 3,87% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $571.799.597 | 7.211.497 | 3,65% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $495.748.197 | 6.252.342 | 3,17% | Aktien |
| ROYAL BANK OF CANADA | $490.209.000 | 6.182.479 | 3,13% | Aktien |
| STATE STREET CORP | $343.710.098 | 4.334.848 | 2,20% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $294.752.810 | 3.584.024 | 1,88% | Aktien |
| TWO SIGMA ADVISERS, LP | $241.452.501 | 3.052.111 | 1,54% | Aktien |
| JPMORGAN CHASE & CO | $216.198.792 | 2.671.717 | 1,38% | Aktien |
| Artisan Partners Limited Partnership | $209.327.536 | 2.640.024 | 1,34% | Aktien |
| Tweedy, Browne Co LLC | $180.805.859 | 2.280.311 | 1,15% | Aktien |
| Deep Track Capital, LP | $174.438.000 | 2.200.000 | 1,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $167.297.540 | 2.109.945 | 1,07% | Aktien |
| BAKER BROS. ADVISORS LP | $162.364.274 | 2.047.727 | 1,04% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $156.967.955 | 1.979.669 | 1,00% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $154.383.816 | 1.947.076 | 0,99% | Aktien |
| FRANKLIN RESOURCES INC | $128.717.601 | 1.623.377 | 0,82% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127.264.731 | 1.605.054 | 0,81% | Aktien |
| BARCLAYS PLC | $127.112.653 | 1.603.136 | 0,81% | Aktien |
| Pictet Asset Management Holding SA | $126.981.913 | 1.596.998 | 0,81% | Aktien |
| Polar Capital Holdings Plc | $115.289.325 | 1.454.021 | 0,74% | Aktien |
| Alyeska Investment Group, L.P. | $112.426.560 | 1.417.916 | 0,72% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $110.805.207 | 1.475.632 | 0,71% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $103.108.716 | 1.300.400 | 0,66% | Kaufoption |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $103.108.000 | 1.300.392 | 0,66% | Aktien |
| MORGAN STANLEY | $101.605.768 | 1.281.444 | 0,65% | Aktien |
| Invesco Ltd. | $88.860.858 | 1.120.707 | 0,57% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $84.114.400 | 1.060.845 | 0,54% | Aktien |
| Bellevue Group AG | $77.090.336 | 972.258 | 0,49% | Aktien |
| GROUPAMA ASSET MANAGMENT | $75.195.315 | 937.083 | 0,48% | Aktien |
| NORTHERN TRUST CORP | $72.440.137 | 913.610 | 0,46% | Aktien |
| Capital International Investors | $65.316.248 | 823.764 | 0,42% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65.184.309 | 822.100 | 0,42% | Verkaufsoption |
| Davern Capital Partners, LP | $63.329.637 | 798.709 | 0,40% | Aktien |
| BANK OF AMERICA CORP /DE/ | $62.717.591 | 790.990 | 0,40% | Aktien |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $62.422.083 | 787.263 | 0,40% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $58.216.225 | 734.219 | 0,37% | Aktien |
| Nuveen, LLC | $57.586.900 | 726.282 | 0,37% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $54.253.072 | 684.236 | 0,35% | Aktien |
| Eversept Partners, LP | $52.702.794 | 664.684 | 0,34% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $51.970.948 | 655.454 | 0,33% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $51.682.490 | 651.816 | 0,33% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $50.232.832 | 633.533 | 0,32% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $50.113.500 | 632.028 | 0,32% | Aktien |
| Caption Management, LLC | $49.952.700 | 630.000 | 0,32% | Kaufoption |
| UBS Group AG | $49.546.260 | 624.874 | 0,32% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. (“Ionis”) ×8 Einreichungen | 13. Oktober 2020 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Isis Pharmaceuticals, Inc. (“ Isis ”) | 31. Juli 2015 | · | Erste Einreichung | · | SEC |
| Isis Pharmaceuticals, Inc. (“Isis”), Stanley T. Crooke (“Crooke”), B. Lynne Parshall (“Parshall”) ×2 Einreichungen | 6. November 2014 | · | Erste Einreichung | · | SEC |
| Genzyme Corporation | 15. Januar 2008 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter | 12. April 2001 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 47 Insider · 30 Führungskräfte · 19 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brett P Monia | Chief Executive Officer | 31. August 2026 J | 242.760 | 0 | 14 | $-30.354.355 |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 16. März 2026 M | 82.660 | 0 | 5 | $-17.867.127 |
| Kleanthis G Xanthopoulos | President of Regulus | 3. Dezember 2007 A | · | 0 | 0 | $0 |
| Brian Birchler | EVP, Corp and Development Ops | 31. August 2026 J | 102.883 | 0 | 6 | $-3.556.351 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 31. August 2026 J | 59.205 | 0 | 6 | $-3.159.716 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 31. August 2026 J | 60.128 | 0 | 10 | $-16.705.490 |
| Holly B. Kordasiewicz | EVP, Chief Development Officer | 7. Juli 2026 S | 22.096 | 0 | 4 | $-4.810.107 |
| Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 26. Juni 2026 M | 77.114 | 0 | 4 | $-3.738.554 |
| Joseph Baroldi | EVP, Chief Business Officer | 26. Juni 2026 M | 4.669 | 0 | 12 | $-2.680.735 |
| Eric Swayze | EVP Research | 25. Juni 2026 S | 21.759 | 0 | 10 | $-5.712.145 |
| Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | 15. April 2026 M | 23.713 | 0 | 4 | $-3.334.240 |
| Shannon L. Devers | EVP, Chief Human Resources Ofc | 2. April 2026 S | 16.348 | 0 | 14 | $-8.661.485 |
| Richard S Geary | EVP, Chief Development Officer | 6. November 2025 M | 59.657 | 0 | 11 | $-9.577.499 |
| Onaiza Cadoret-Manier | EVP,Chf GL Pdt Str & Oper Ofc | 2. Februar 2024 S | 35.788 | 0 | 0 | $0 |
| Stanley T Crooke | Exec Chairman of the Board | 26. Januar 2021 S | 2.021 | 0 | 0 | $0 |
| Damien Mcdevitt | Chief Business Officer | 15. Juli 2019 M | 2.573 | 0 | 0 | $0 |
| Sarah Boyce | Chief Business Officer | 15. Januar 2018 M | 8.931 | 0 | 0 | $0 |
| ECKER DAVID J | Vice President | 2. September 2008 M | 0 | 0 | 0 | $0 |
| Michael J Treble | Vice President, Pres of Ibis | 11. August 2008 M | 0 | 0 | 0 | $0 |
| Jeffrey M Jonas | Executive Vice President | 2. Januar 2008 A | · | 0 | 0 | $0 |
| Mark K Wedel | VP & Chief Medical Officer | 6. Juli 2007 M | 6.603 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Vice President | 25. April 2007 M | 1.674 | 0 | 0 | $0 |
| BROWN RICHARD K | Vice President | 8. März 2006 M | 2.348 | 0 | 0 | $0 |
| MCNEIL JOHN A | Vice President | 3. Januar 2005 A | · | 0 | 0 | $0 |
| LOWENSTAM PATRICIA | Vice President | 3. Januar 2005 A | 603 | 0 | 0 | $0 |
| STEIN ARON | Vice President | 1. Juli 2004 J | 1.536 | 0 | 0 | $0 |
| Hans A De Haan | VP, Drug Development | 27. April 2004 S | 0 | 0 | 0 | $0 |
| LUNDSTEDT KAREN S | Vice President | 10. März 2004 M | 5.407 | 0 | 0 | $0 |
| COLE DOUGLAS L | Vice President | 9. März 2004 M | 9.616 | 0 | 0 | $0 |
| HOLMLUND JON T | Vice President | 1. Juli 2003 J | 983 | 0 | 0 | $0 |
| Michael R Hayden | Direktor | 31. Juli 2026 P | 24.000 | 2 | 0 | $1.058.700 |
| Peter N Reikes | Direktor | 15. Juli 2026 A | 14.222 | 0 | 0 | $0 |
| Ludwig Hantson | Direktor | 15. Juli 2026 A | · | 0 | 0 | $0 |
| Joan E Herman | Direktor | 15. Juli 2026 M | 51.306 | 0 | 2 | $-3.173.720 |
| BERTHELSEN SPENCER R | Direktor | 15. Juli 2026 M | 161.233 | 0 | 2 | $-1.193.280 |
| Allene M. Diaz | Direktor | 7. Juli 2026 M | 3.811 | 0 | 4 | $-5.218.027 |
| Michael J. Yang | Direktor | 1. Juli 2026 A | 7.940 | 0 | 0 | $0 |
| Joseph Loscalzo | Direktor | 1. Juli 2026 A | 36.330 | 0 | 5 | $-7.085.472 |
| Joseph Klein III | Direktor | 1. Juli 2026 A | 11.014 | 0 | 12 | $-5.996.036 |
| Lynne B Parshall | Direktor | 15. April 2026 S | 51.344 | 0 | 4 | $-1.153.667 |
| Joseph H Wender | Direktor | 1. Dezember 2025 S | 36.035 | 0 | 6 | $-4.335.515 |
| MUTO FREDERICK T | Direktor | 15. Juli 2022 M | 59.597 | 0 | 0 | $0 |
| Breaux Castleman | Direktor | 1. Juli 2020 A | 19.183 | 0 | 0 | $0 |
| REED JOHN C | Direktor | 6. September 2012 M | 0 | 0 | 0 | $0 |
| Richard D Dimarchi | Direktor | 1. Juli 2010 A | · | 0 | 0 | $0 |
| GARIELI CHRISTOPHER | Direktor | 1. Juli 2005 A | 155.431 | 0 | 0 | $0 |
| SKALETSKY MARK B | Direktor | 1. Juli 2004 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 59 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1,77% | 531.633 NS | 31. Juli 2026 | N-PORT |
| BBP · ETFis Series Trust I | 0,97% | 18.522 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,89% | 179.574 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,67% | 1.239.007 SH | 11. September 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,61% | 151.535 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,49% | 11.744 SH | 1. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,48% | 46.023 NS | 31. Juli 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,38% | 98.367 SH | 1. Oktober 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,34% | 2.078.639 SH | 19. August 2026 | Täglich |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,31% | 34.728 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,30% | 52.262 SH | 11. September 2026 | Täglich |
| IWP · iShares Trust | 0,25% | 873.674 SH | 11. September 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,21% | 26.705 NS | 31. Juli 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,20% | 1.631 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,20% | 50.927 SH | 19. August 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 72.134 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 471.609 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,18% | 106.774 SH | 1. Oktober 2026 | Täglich |
| ESML · iShares Trust | 0,16% | 78.845 SH | 11. September 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,15% | 74.249 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,15% | 1.895.610 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,15% | 3.600.281 SH | 19. August 2026 | Täglich |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 71.364 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,15% | 96.087 SH | 11. September 2026 | Täglich |
| FFLG · FIDELITY COVINGTON TRUST | 0,14% | 16.403 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,14% | 629 NS | 31. Juli 2026 | N-PORT |
| SMMD · iShares Trust | 0,13% | 87.867 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 74.568 NS | 31. Juli 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,10% | 25.981 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 10.429 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 9.648 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,08% | 13.559 SH | 1. Oktober 2026 | Täglich |
| IWR · iShares Trust | 0,07% | 673.792 SH | 11. September 2026 | Täglich |
| LRND · New York Life Investments ETF Trust | 0,05% | 3.731 NS | 31. Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 244.940 SH | 19. August 2026 | Täglich |
| DYNF · BlackRock ETF Trust | 0,04% | 269.218 SH | 11. September 2026 | Täglich |
| IWF · iShares Trust | 0,03% | 582.970 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 4.990.066 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 27.263 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 13.860 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 37.171 SH | 19. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 6.110 NS | 31. Juli 2026 | N-PORT |
| IWB · iShares Trust | 0,01% | 113.547 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,01% | 6.926 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 218.402 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 45.548 SH | 10. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,01% | 14.074 NS | 31. Juli 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 144.631 SH | 19. August 2026 | Täglich |
| IWS · iShares Trust | 0,01% | 13.733 SH | 10. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 2.712 NS | 31. Juli 2026 | N-PORT |
| IWD · iShares Trust | 0,00% | 20.479 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 5.654 NS | 31. Juli 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,00% | 82 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1.669 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 236 NS | 31. Juli 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.617 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 7.426 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 134.548 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 15.473 SH | 1. September 2026 | Täglich |
IONS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 32 Analysten
KAUF
Median-Ziel
$85.00
+95,2%
8 25,0%
Starker Kauf
17 53,1%
Kauf
7 21,9%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
22 Analysten · 2026-09-29Mittelwert-Ziel $83.64 +92,1%
← Unter allen Zielen
Aktueller Preis $43.54
Tief$54.00
Mittelwert$83.64
Hoch$105.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IONS | $12.92B | -33.2 | · | · | -68.1% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
| IMVT | $5.07B | -9.0 | 229.2% | · | -73.7% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 29, 2026